首页> 外文会议>Mediterranean Conference on Medical and Biological Engineering and Computin >Novel Methods for Correcting Next Generation Sequencing Errors in the β Chain of T Cell Receptors
【24h】

Novel Methods for Correcting Next Generation Sequencing Errors in the β Chain of T Cell Receptors

机译:用于校正T细胞受体β链中下一代测序误差的新方法

获取原文

摘要

Next generation sequencing (NGS) promises to revolutionize the various areas of the omics family by skyrocketing the throughput by which sequencing data become available. In immunogenetics, substantial effort has been put on the analysis of the repertoire of T cell receptors (TCR), one of the main weapons of the adaptive immune system, since this analysis is of great significance for the study of lymphoid malignancies, such as the Chronic Lymphocytic Leukemia (CLL). However, sequencing errors, inherent even in traditional low-throughput sequencing, can interfere with repertoire analysis, possibly misleading the immunogenetic interpretation of the analysis outcomes. The high sequencing error rate of NGS aggravates the problem even further. In this paper, we propose two novel error correction methods that are applied sequentially to NGS data acquired from the TCR β chain. Both methods focus on the highly variable Complementarity Determining Region 3 (CDR3) of the TCR. First, we attempt to revise the boundaries of the non-template parts of CDR3 that have been extracted by a third-party immunogenetic annotation tool, and then we correct the V- and J-gene parts of the CDR3 based on template germline V- and J-genes. The proposed methods have undergone preliminary evaluation on TCR β chain NGS data of two CLL patients, yielding promising results.
机译:下一代测序(NGS)承诺通过将测序数据可用的吞吐量进行吞吐量来彻底旋转OMICS系列的各个区域。在免疫遗传学,实质性的努力已经提上T细胞受体(TCR)的适应性免疫系统的主要武器之一的剧目的分析,因为这种分析具有重要意义的淋巴组织的恶性肿瘤,如的研究慢性淋巴细胞白血病(CLL)。然而,即使在传统的低通量测序中固有的序列误差也可以干扰再胃分析,可能误导分析结果的免疫原解释。 NGS的高测序误差率进一步加剧了问题。在本文中,我们提出了两种新的误差校正方法,该纠错方法依次施加到从TCRβ链中获取的NGS数据。这两种方法都侧重于TCR的高度可变互补确定区域3(CDR3)。首先,我们试图修改已被第三方免疫原性注释工具提取的CDR3的非模板部分的界限,然后我们校正基于模板种系V-的CDR3的V-和J-GENE部分和J-基因。所提出的方法对两种CLL患者的TCRβ链NGS数据进行了初步评价,产生了有希望的结果。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号